Original article

Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders

S Oertle, H Mauron, PN Villiger

DOI: https://doi.org/10.4414/smw.2002.10031
Publication Date: 27.07.2002
Swiss Med Wkly. 2002;132(29-30):414